Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
First Claim
Patent Images
1. A method for improvement of glycemic control in a patient having diabetes type 2, comprising administering to the patient a therapeutically effective amount of the pharmaceutical combination comprising:
- (a) desPro36Exendin-4(1-39)-Lys6-NH2 and/or a pharmaceutically acceptable salt thereof, and(b) a glitazone and/or a pharmaceutically acceptable salt thereof; and
wherein the patient has a haemoglobin A1c (HbA1c) value of at least 8% and a fasting plasma glucose of at least 9 mmol/L when treated with glitazone alone.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients.
-
Citations
2 Claims
-
1. A method for improvement of glycemic control in a patient having diabetes type 2, comprising administering to the patient a therapeutically effective amount of the pharmaceutical combination comprising:
-
(a) desPro36Exendin-4(1-39)-Lys6-NH2 and/or a pharmaceutically acceptable salt thereof, and (b) a glitazone and/or a pharmaceutically acceptable salt thereof; and wherein the patient has a haemoglobin A1c (HbA1c) value of at least 8% and a fasting plasma glucose of at least 9 mmol/L when treated with glitazone alone. - View Dependent Claims (2)
-
Specification